Innovative treatment targets blood clots without increased bleeding risk
The development of MPI 8 represents a major breakthrough in the field of blood clot prevention and treatment, said Dr. Jayachandran Kizhakkedathu.
Hot bees are dead bees
With the support of a CBR Transition Grant, Dr. Alison McAfee is investigating how different types of bees withstand hot temperatures.
New Treatment Option for a Deadly Muscle Disease: An Arduous Journey for the Advancement of Medicine
Dr. Farshad Babaeijandaghi and the Rossi Lab have discovered a new drug that could help treat Duchenne’s muscular dystrophy.
Emerging artificial intelligence methods to assess transfusion quality
Research from Dr. Hongshen Ma’s lab describes how machine learning and artificial intelligence can help assess transfusion quality.
CBR scientists receive federal support to advance mRNA vaccine technologies
Dr. Leonard Foster and Dr. Natalie Strynadka have received $11.1 million for research on the delivery and efficacy of mRNA vaccines.
“Squeeze-ability” of a red blood cell: The deformability of red blood cells is a useful biomarker for storage quality
CBR scientists found that red blood cell deformability – its ability to squeeze and change shape – could be a useful biomarker for storage quality.
Dr. Kelly Brown leads evaluation of the utility of adult-defined biomarkers in pediatric vasculitis with CIHR Fall 2021 Project Grant
With a CIHR Fall 2021 Project Grant, Dr. Kelly Brown is leading a project to better understand and treat pediatric vasculitis.
UBC 3MT finalist calls for more science communication
UBC 3MT finalist Nicolas Pereyra shares his research on extending the shelf-life of platelets, and thoughts on science communication.
Research answers questions about infusion pumps’ effect on red blood cells
A study from Dr. Narges Hadjesfandiari and colleagues investigates infusion pumps’ effect on red blood cells.
Cancer drug shows potential as treatment for muscular dystrophy
UBC researchers have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy.